Zhao Yan's new drug: stock price has risen by over 20% for three consecutive days.

According to the announcement of Zhaoyan New Drugs, the company's stock has experienced abnormal fluctuations in trading for three consecutive trading days on July 25th, 28th, and 29th in 2025, with a cumulative deviation of more than 20% in the closing prices. After a self-examination and written consultation with the company's controlling shareholder and actual controller, it was confirmed that there is no significant information that should have been disclosed but was not disclosed. The company's production and operation activities are normal, and there have been no significant changes in internal and external operating environments. There is no significant information that should have been disclosed but was not disclosed that could have affected the abnormal fluctuations in the company's stock trading prices.